Patent details

Basic Information

Publication number:

EP3191517

PCT Application Number:

EP2015070550

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP157625625

PCT Publication Number:

WO2016038064

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CROSS REACTIVE SIGLEC ANTIBODIES

French Title of Invention:

ANTICORPS ANTI-SIGLEC À RÉACTION CROISÉE

German Title of Invention:

KREUZREAKTIVE SIGLEC-ANTIKÖRPER

SPC Number:

Dates

Filing date:

09/09/2015

Grant date:

04/11/2020

EP Publication Date:

19/07/2017

PCT Publication Date:

17/03/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/11/2020

EP B1 Publication Date:

04/11/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/09/2021

Expiration date:

09/09/2035

Renunciation date:

Revocation date:

11/03/2023

Annulment date:

Owner

From:

28/10/2020

 

 

Name:

Innate Pharma

Address:

117, Avenue de Luminy, 13009 Marseille, France (FR)

Inventor

1

Name:

CORNEN, Stéphanie

Address:

France (FR)

2

Name:

ROSSI, Benjamin

Address:

France (FR)

3

Name:

WAGTMANN, Nicolaï

Address:

France (FR)

Priority

Priority Number:

201462048292 P

Priority Date:

10/09/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61P 35/00; C07K 16/28;

Publication

European Patent Bulletin

1

Issue number:

202045

Publication date:

04/11/2020

Description:

Grant (B1)

2

Issue number:

202329

Publication date:

19/07/2023

Description:

Revocation of the European patent

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages